Atlas Trials

pharmaand GmbH

22 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch pharmaand GmbH

RecordFirmDate
CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib (NCT04676334)pharmaand GmbH2021-03-22
A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes (NCT04171700)pharmaand GmbH2020-01-16
Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP) (NCT04179396)pharmaand GmbH2019-12-05
A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat (NCT04150289)pharmaand GmbH2019-11-04
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) (NCT03824704)pharmaand GmbH2019-08-23
A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR) (NCT03992131)pharmaand GmbH2019-06-28
Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives (NCT03954366)pharmaand GmbH2019-04-25
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma (NCT03397394)pharmaand GmbH2018-06-01
Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor (NCT03521037)pharmaand GmbH2018-02-27
A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor (NCT03499444)pharmaand GmbH2018-02-06

Track pharmaand GmbH automatically

Every clearance here is in the API, with alerts when new ones post.